Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $148.8400 (1.15%) ($147.7600 - $150.1100) on Wed. Mar. 9, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.03% (three month average) | RSI | 58 | Latest Price | $148.8400(1.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.1% a day on average for past five trading days. | Weekly Trend | ABBV advances 1.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(43%) SPLV(34%) XLP(31%) DIA(30%) VYM(30%) | Factors Impacting ABBV price | ABBV will decline at least -0.515% in a week (0% probabilities). VIXM(-19%) UUP(-12%) TBT(-3%) VXX(1%) UNG(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.515% (StdDev 1.03%) | Hourly BBV | 0.6 () | Intraday Trend | 0.5% | | | |
|
5 Day Moving Average | $149.28(-0.29%) | 10 Day Moving Average | $148.66(0.12%) | 20 Day Moving Average | $146.6(1.53%) | To recent high | -1.1% | To recent low | 19.9% | Market Cap | $262.596b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |